Gurjot Kaur

About

Currently, I am teaching human genetics at Panjab University, India. I have been employed as an Associate Professor, Pharmacology and Toxicology at Shoolini University. Previous experience include post-doctoral researcher at Human and Environmental Toxicology group, University of Konstanz, Germany. My main research interests include ‘Transporters and Ion channels involved in toxicity in Humans’ . I hold expertise in molecular and cellular biology techniques and I am very passionate about environmental preservation.

Employment

• Panjab University G. Asst. Professor
  2022 - Present
• Shoolini University Associate Professor
  2019 - 2021
• University of Konstanz Post-doctoral fellow, Research Associate
  2016 - 2019
• University of Konstanz Post-doctoral Fellow, Research Associate
  2014 - 2016

Education

• University of Innsbruck PhD
  2009 - 2013
• National Institute of Pharmaceutical Education and Research Masters
  2006 - 2008
• Delhi Institute of Pharmaceutical Sciences and Research Bachelors
  2002 - 2006

Projects & Funding

Projects & funding information is unavailable.

Publications (26)

• Harnessing phytoconstituents to treat COVID-19 triggered acute respiratory distress syndrome: Insights from network pharmacology, and molecular modeling
  Phytochemistry Letters 2026 DOI: 10.1016/j.phytol.2025.104105
  +Save
• Phytoconstituents as modulator of inflammatory pathways for COVID‐19: A comprehensive review and recommendations
  Phytotherapy Research 2024 DOI: 10.1002/ptr.8302
  +Save
• Scientometric analysis and identification of research trends in microplastic research for 2011–2019
  Environmental Science and Pollution Research 2022 DOI: 10.1007/s11356-022-20872-0
  +Save
• Herb–drug interactions: a mechanistic approach
  Drug and Chemical Toxicology 2022 DOI: 10.1080/01480545.2020.1738454
  +Save
• COVID-19 Mechanisms in the Human Body-What We Know So Far.
  Frontiers in immunology 2021 DOI: 10.3389/fimmu.2021.693938
  +Save
• COVID-19 Mechanisms in the Human Body—What We Know So Far
  OpenAlex 2021 DOI: 10.60692/sr4ks-a5a68
  +Save
• COVID-19 Mechanisms in the Human Body—What We Know So Far
  OpenAlex 2021 DOI: 10.60692/q2e4j-tr753
  +Save
• Demographic characteristics of SARS-CoV-2 B.1.617.2 (Delta) variant infections in Indian population
  [] 2021 DOI: 10.1101/2021.09.23.21263948
  +Save
• Scientometric Analysis and Identification of Research Trends in Microplastics Research for 2011-2019
  2021 DOI: 10.21203/rs.3.rs-759818/v1
  +Save
• Flavan-based phytoconstituents inhibit Mpro, a SARS-COV-2 molecular target, in silico.
  Journal of biomolecular structure & dynamics 2021 DOI: 10.1080/07391102.2021.1960196
  +Save